Last reviewed · How we verify
liposomal bupivacaine plus free bupivacaine
liposomal bupivacaine plus free bupivacaine is a Small molecule drug developed by The Cleveland Clinic. It is currently in Phase 1 development.
At a glance
| Generic name | liposomal bupivacaine plus free bupivacaine |
|---|---|
| Sponsor | The Cleveland Clinic |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Nausea
- Hypotension
- Nausea and vomiting
- Postoperative neurologic symptoms at 7 days after surgery
- Bruising
- Pruritus
- Dry mouth
- Sedation
- Rash
- Swelling
- Inflammation
- Ringing in ears
Key clinical trials
- Liposomal Bupivacaine vs Perineural Adjuvants in Adductor Canalf and iPACK Blocks in Total Knee Arthroplasty (PHASE4)
- Efficacy of EXPAREL vs. Bupivacaine (PHASE3)
- TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant (PHASE4)
- Effect of Intrathecal Morphine on Quality of Recovery After Laparoscopic Gynecological Surgery (NA)
- Pectoralis and Serratus Muscle Blocks (PHASE4)
- The Use of Pecs Blocks in Combination With Exparel in Breast Reconstruction Surgery (PHASE3)
- Does an Abdominal Wall Nerve Block During Surgery Help Reduce Pain From Kidney Transplantation? (NA)
- Pectoral Fascial Plane and Serratus Anterior Plane Blocks With Bupivacaine v. Liposomal Bupivacaine (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- liposomal bupivacaine plus free bupivacaine CI brief — competitive landscape report
- liposomal bupivacaine plus free bupivacaine updates RSS · CI watch RSS
- The Cleveland Clinic portfolio CI
Frequently asked questions about liposomal bupivacaine plus free bupivacaine
What is liposomal bupivacaine plus free bupivacaine?
liposomal bupivacaine plus free bupivacaine is a Small molecule drug developed by The Cleveland Clinic.
Who makes liposomal bupivacaine plus free bupivacaine?
liposomal bupivacaine plus free bupivacaine is developed by The Cleveland Clinic (see full The Cleveland Clinic pipeline at /company/the-cleveland-clinic).
What development phase is liposomal bupivacaine plus free bupivacaine in?
liposomal bupivacaine plus free bupivacaine is in Phase 1.
What are the side effects of liposomal bupivacaine plus free bupivacaine?
Common side effects of liposomal bupivacaine plus free bupivacaine include Nausea, Hypotension, Nausea and vomiting, Postoperative neurologic symptoms at 7 days after surgery, Bruising, Pruritus.